Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans

Author(s): Diego Fiume, Ilaria Lenci, Martina Milana, Tommaso M. Manzia, Renato Massoud, Laura Tariciotti, Carmelo Russo, Luca Toti, Leonardo Baiocchi*

Journal Name: Reviews on Recent Clinical Trials

Volume 15 , Issue 2 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Multiple biological functions have been recognized regarding Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) and Stem Cell Factor (SCF).

Aim: To evaluate the serum changes of GM-CSF and SCF in patients undergoing surgical resection for liver tumor, in the regenerative phase after surgery in order to identify the possible relationship with the patient, tumor or surgical variables.

Methods: Thirty-two consecutive patients (50% male, median age 66), undergoing hepatic resection of liver neoplasm, were evaluated. The liver tumor was Hepatocellular Carcinoma (HCC) in 44% of cases. Other tumors were cholangiocarcinoma and metastasis. Serum levels of GM-CSF and SCF were assessed at baseline and 2 days, 7 days and 4 weeks after surgery. Personal and clinical patient data were also recorded. The statistical analysis was carried out using t-test for unpaired data or ANOVA (repeated measure) for continuous variables and Fisher test for discrete variables.

Results: GM-CSF levels remained constant after surgery and were compared to baseline values. SCF levels, on the other hand, increased during the time, after surgery. The evaluation of SCF levels (fold increase) according to surgical, patient and tumor variables evidenced some differences. At day 7 and week 4, SCF levels were statistically increased: i) in patients undergoing a large resection in comparison with others (p<0.05); ii) in patients non-cirrhotic in comparison with cirrhotic ones (p=0.02) and finally; iii) in patients with non-HCC tumor in comparison with HCC ones (p=0.02).

Conclusion: During liver regeneration in humans, SCF serum levels are increased allowing to hypothesize a possible role of this chemokine during tissue growth and remodeling.

Keywords: Granulocyte-macrophage-cell-stem factor, hepatocellular carcinoma, human, liver resection, liver tumor, stem cell factor.

[1]
Kamijo T, Koike K, Nakazawa Y, Takeuchi K, Ishii E, Komiyama A. Synergism between stem cell factor and granulocyte-macrophage colony-stimulating factor on cell proliferation by induction of cyclins. Cytokine 2002; 19(6): 267-75.
[http://dx.doi.org/10.1006/cyto.2002.1966] [PMID: 12421569]
[2]
Becher B, Tugues S, Greter M. GM-CSF: From growth factor to central mediator of tissue inflammation. Immunity 2016; 45(5): 963-73.
[http://dx.doi.org/10.1016/j.immuni.2016.10.026] [PMID: 27851925]
[3]
Broudy VC. Stem cell factor and hematopoiesis. Blood 1997; 90(4): 1345-64.
[http://dx.doi.org/10.1182/blood.V90.4.1345] [PMID: 9269751]
[4]
Peralta C, Jiménez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol 2013; 59(5): 1094-106.
[http://dx.doi.org/10.1016/j.jhep.2013.06.017] [PMID: 23811302]
[5]
Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol 2015; 5: S104-15.
[http://dx.doi.org/10.1016/j.jceh.2014.11.005]
[6]
Hu B, Colletti LM. Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2008; 295(1): G45-53.
[http://dx.doi.org/10.1152/ajpgi.00024.2008] [PMID: 18467506]
[7]
Meng F, Francis H, Glaser S, et al. Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration. Hepatology 2012; 55(1): 209-21.
[http://dx.doi.org/10.1002/hep.24673] [PMID: 21932404]
[8]
Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987; 206(1): 30-9.
[http://dx.doi.org/10.1097/00000658-198707000-00005] [PMID: 3038039]
[9]
Mao SA, Glorioso JM, Nyberg SL. Liver regeneration. Transl Res 2014; 163(4): 352-62.
[http://dx.doi.org/10.1016/j.trsl.2014.01.005] [PMID: 24495569]
[10]
Okumoto K, Saito T, Onodera M, et al. Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis. J Gastroenterol Hepatol 2007; 22(8): 1265-70.
[http://dx.doi.org/10.1111/j.1440-1746.2006.04497.x] [PMID: 17688667]
[11]
Baccarani U, De Stasio G, Adani GL, et al. Implication of stem cell factor in human liver regeneration after transplantation and resection. Growth Factors 2006; 24(2): 107-10.
[http://dx.doi.org/10.1080/08977190600560636] [PMID: 16801130]
[12]
Swenson ES, Kuwahara R, Krause DS, Theise ND. Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int 2008; 28(3): 308-18.
[http://dx.doi.org/10.1111/j.1478-3231.2007.01659.x] [PMID: 18290773]
[13]
Dezső K, Rókusz A, Bugyik E, et al. Human liver regeneration in advanced cirrhosis is organized by the portal tree. J Hepatol 2017; 66(4): 778-86.
[http://dx.doi.org/10.1016/j.jhep.2016.11.014] [PMID: 27913222]
[14]
Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res 2008; 331(1): 283-300.
[http://dx.doi.org/10.1007/s00441-007-0542-z] [PMID: 18046579]
[15]
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018; 391(10127): 1301-14.
[http://dx.doi.org/10.1016/S0140-6736(18)30010-2] [PMID: 29307467]
[16]
Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42(5): 341-7.
[http://dx.doi.org/10.1016/j.dld.2009.09.002] [PMID: 19828388]
[17]
Giannini EG, Marenco S, Bruzzone L, et al. Hepatocellular carcinoma in patients without cirrhosis in Italy. Dig Liver Dis 2013; 45(2): 164-9.
[http://dx.doi.org/10.1016/j.dld.2012.08.018] [PMID: 23047000]
[18]
Wang X, Ren H, Zhao T, et al. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Carcinogenesis 2014; 35(10): 2283-90.
[http://dx.doi.org/10.1093/carcin/bgu162] [PMID: 25086759]
[19]
Mansuroglu T, Ramadori P, Dudás J, et al. Expression of stem cell factor and its receptor c-Kit during the development of intrahepatic cholangiocarcinoma. Lab Invest 2009; 89(5): 562-74.
[http://dx.doi.org/10.1038/labinvest.2009.15] [PMID: 19255573]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 2
Year: 2020
Page: [131 - 136]
Pages: 6
DOI: 10.2174/1574887115666200123113623
Price: $65

Article Metrics

PDF: 18
HTML: 4